A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
Completed · Phase 2 · Has a placebo group
Conditions studied: Obesity
In brief
The purpose of this study is to determine the effect of nasal PYY3-36 on weight loss post 24 weeks of treatment.
Key facts
- Study ID
- NCT00537420
- Run by
- Nastech Pharmaceutical Company, Inc.
- People needed
- 551
- Starts
- 2007-10-01
- Expected to finish
- 2008-09-01
- Last updated by the study team
- 2008-09-15
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or Female patients 18 and 65 years, inclusive;
- BMI 30-43 kg/m2, inclusive;
- In good health, determined by medical history and physical examination, as well as normal 12-lead ECG and vital signs;
- Non-smoker and no use of tobacco or nicotine products for at least 3 months;
- Females will be non-pregnant, non-lactating, and either post-menopausal for at least 1 year, surgically sterile (including tubal ligation, hysterectomy) for at least 3 months, until 30 days following Study Completion be willing to use an approved method of contraception;
- Has normal nasal mucosa.
You may not qualify if…
- Previous surgical treatment for obesity;
- Serious Medical Condition
- Serious Psychiatric illness
- Organic causes of obesity (e.g. untreated hypothyroidism)
- Type 1 or Type 2 Diabetes;
- Presence of uncontrolled hypertension
- On prohibited concomitant medication
Where it is running
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Peoria, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Phoenix, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Anaheim, California, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Beverly Hills, California, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Carmichael, California, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Orange, California, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Sacramento, California, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — San Diego, California, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — San Diego, California, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — San Francisco, California, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Pembroke Pines, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Atlanta, Georgia, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Augusta, Georgia, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Evansville, Indiana, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Valparaiso, Indiana, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Baton Rouge, Louisiana, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Brooklyn Center, Minnesota, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Las Vegas, Nevada, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Manlius, New York, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Charlotte, North Carolina, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Raleigh, North Carolina, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Cleveland, Ohio, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Reading, Pennsylvania, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Greer, South Carolina, United States
- For additional information regarding investigative sites for this trial, contact 1-425-415-3011 — Mt. Pleasant, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.